Actionnariat et activité des initiés pour Quince Therapeutics, Inc. (QNCX): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $27.17 |
| Capitalisation | $8M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-06-11 | Lamond David | A-Award | 2,700 | $3K |
| 2026-06-11 | Senner Christopher J. | A-Award | 2,700 | $3K |
| 2026-05-18 | Roberts Brigette | A-Award | 6,837,319 | $5.7M |
| 2026-05-18 | Roberts Brigette | A-Award | 2,070,107 | $186K |
| 2026-05-18 | Roberts Brigette | A-Award | 362,092 | $33K |
| 2026-05-18 | Roberts Brigette | A-Award | 228,855 | $21K |
| 2026-05-18 | Roberts Brigette | A-Award | 133,615 | $12K |
| 2026-05-18 | Roberts Brigette | A-Award | 124,830 | $11K |
| 2026-05-18 | Roberts Brigette | A-Award | 69,350 | $6K |
| 2026-05-18 | Roberts Brigette | A-Award | 34,675 | $3K |
Bilan (10 ans)
| Année | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $7.3M | $24.9M | $51.2M | $66.8M | $69.7M | $44.6M | $20.8M | $6.2M | $5.8M |
| Placements à Court Terme | 0 | $46.8M | $48.6M | $67.0M | $37.1M | $45.6M | $54.3M | $34.6M | $11.9M |
| Créances | 0 | 0 | 0 | 0 | $1.1M | 0 | $993000 | $882000 | $3.6M |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $7.5M | $72.6M | $106.1M | $137.9M | $111.7M | $93.7M | $77.4M | $44.0M | $22.9M |
| Immobilisations Corporelles | $122000 | $283000 | $1.3M | $1.1M | $1.4M | $684000 | $619000 | $813000 | $1.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | $17.6M | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | $5.9M | $63.7M | $60.0M | $67.8M |
| Actifs Totaux | $7.7M | $72.9M | $124.4M | $189.5M | $133.2M | $103.9M | $180.2M | $114.5M | $93.5M |
| Dettes Fournisseurs | $517000 | $495000 | $3.1M | $3.6M | $4.9M | $570000 | $2.0M | $2.9M | $2.2M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | $64000 | 0 | $18.0M |
| Passifs Courants | $1.8M | $1.5M | $8.9M | $17.0M | $14.2M | $3.1M | $9.6M | $7.3M | $43.2M |
| Dette à Long Terme | $7.2M | 0 | 0 | 0 | 0 | 0 | $13.4M | $14.3M | $330000 |
| Passifs Totaux | $28.0M | $1.5M | $8.9M | $17.2M | $14.6M | $3.3M | $95.1M | $84.3M | $129.2M |
| Réserves | -$20.3M | -$32.8M | -$69.8M | -$146.7M | -$236.6M | -$288.3M | -$319.6M | -$376.5M | -$460.5M |
| Capitaux Propres | -$20.3M | $71.4M | $115.5M | $172.3M | $118.6M | $100.6M | $85.1M | $30.1M | -$35.7M |
| Dette Totale | $7.2M | 0 | 0 | $446000 | $1.2M | $453000 | $13.8M | $14.8M | $18.5M |
| Dette Nette | -$172000 | -$71.7M | -$99.9M | -$133.4M | -$105.6M | -$89.7M | -$61.2M | -$26.0M | $719000 |
| Fonds de Roulement | $5.8M | $71.1M | $97.2M | $120.9M | $97.5M | $90.7M | $67.9M | $36.8M | -$20.3M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 14.52 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -8.15 |
Rentabilité
| Rentabilité des capitaux propres | -413.28% |
| Rentabilité du capital investi | -104.64% |
| Rentabilité des actifs | -74.58% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ADVM · ALXO · ATYR · CAMP · CNTB · DTIL · GUTS
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de QNCX: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions